Genshin Impact announced a new collaboration during the 5.6 special program. During this livestream, the developers announced a partnership with cosmetics brand Charlotte Tilbury.

Pfizer also got the nod for Staquis (crisaborole), a topical phosphodiesterase 4 (PDE-4) inhibitor for atopic dermatitis already sold as Eucrisa in the US since 2016. The US drugmaker also had a ...